FDA approves MRTP for 20 ZYN pouches

The U.S. Food and Drug Administration has issued a Modified Risk Tobacco Product (MRTP) authorization for twenty types of ZYN nicotine pouches. This is the first time the agency has granted such approval for non-combustible tobacco products. The authorization allows Philip Morris to clarify that replacing cigarettes with ZYN pouches reduces the risks of smoking-related diseases, such as heart disease, cancer, lung cancer, and stroke, in accordance with specified conditions. This decision is part of the company's efforts to build a smoke-free future, as ZYN is considered an alternative that reduces exposure to harmful substances associated with smoking, helping to decrease addiction and improve the overall health of adult smokers.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل